BA.3.2.* has been shown to be preferentially infecting children. In the US, this is most apparent in New York (state), which has reported most of the BA.3.2.* samples and also shares Patient age data. Among children (0-17), BA.3.2.* reached 17% (n=22), vs 2% among adults (n=12), so a ~7X higher rate among children. 🧵